Copyright
©The Author(s) 2004.
World J Gastroenterol. Oct 1, 2004; 10(19): 2874-2877
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2874
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2874
Figure 1 Detection of the recombinant plasmid pVAX-sEN using EcoR I and Kpn I digestion.
A: Marker15000; B: pVAX1 digested by EcoR I; C: Recombinant plasmid pVAX-sEN digested by EcoR I; D: Recombinant plasmid pVAX-sEN digested by EcoR I and Kpn I.
Figure 2 Comparison of in vivo transfection using different ratios of liposome and DNA in liposome-DNA complex and naked DNA.
Figure 3 Comparison of in vivo transfection using liposome complex (the ratio of liposome and DNA is 1:1) containing different doses of DNA.
Figure 4 Inhibitory effect of recombinant secretive endostatin on mouse hepatoma cells.
Figure 5 In vivo endostatin expression in peripheral blood of treated mice.
Figure 6 Inhibition of tumor neovascularization by injecting recombinant plasmid.
-
Citation: Ma CH, Zhang Y, Wang XY, Gao LF, Liu H, Guo C, Liu SX, Cao YL, Zhang LN, Sun WS. Human endostatin gene transfer, either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells
in vivo . World J Gastroenterol 2004; 10(19): 2874-2877 - URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2874.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i19.2874